指南与共识分子诊断临床微生物

临床标本直接宏基因组病原检测的临床应用、局限性与检测建议

Navigating Clinical Utilization of Direct-from-Specimen Metagenomic Pathogen Detection: Clinical Applications, Limitations, and Testing Recommendations.
指南 / 共识 · Clin Chem · 2020-01-01

该综述回顾了脑脊液、血浆、下呼吸道等标本类型中mNGS用于病原检测的临床研究,评估其临床影响与局限性并给出早期检测建议。已发表研究中mNGS检测带来阳性临床影响的比例较低且费用高,强调需明确何时检测及适用患者。

要点

  • mNGS在脑膜炎/脑炎、侵袭性真菌感染、社区获得性肺炎等适应症中显示诊断潜力
  • 已发表研究中mNGS检测阳性临床影响比例低且费用高
  • 需明确mNGS检测的适用患者与时机以优化临床利用

核心结论

  • mNGS对挑战性感染诊断有潜力,但阳性临床影响比例低且费用高,需明确何时检测及适用患者。

研究设计与样本

  • 综述了脑脊液、血浆、下呼吸道标本等多种标本类型中mNGS用于病原检测的临床研究。

主要发现

  • 早期临床研究在脑膜炎或脑炎、侵袭性真菌感染、社区获得性肺炎等适应症中显示了mNGS的诊断潜力。
  • 已发表研究中mNGS检测带来阳性临床影响的患者比例较低且检测费用高。

关键数值与推荐

  • 基于临床研究提出早期检测建议以指导mNGS病原检测的临床利用。
  • 强调需改善对「何时检测」及哪些患者适合mNGS检测的理解。

临床怎么用

  • 临床应参考早期检测建议,在脑膜炎或脑炎、侵袭性真菌感染、社区获得性肺炎等适应症中合理使用mNGS。
  • 需关注检测费用高及阳性临床影响比例低的问题,选择合适患者进行检测。

局限性

  • mNGS在临床微生物学中的最佳作用仍不确定。
  • 常规临床实验室实施mNGS检测仍存在障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metagenomic next generation sequencing (mNGS) is becoming increasingly available for pathogen detection directly from clinical specimens. These tests use target-independent, shotgun sequencing to detect potentially unlimited organisms. The promise of this methodology to aid infection diagnosis is demonstrated through early case reports and clinical studies. However, the optimal role of mNGS in clinical microbiology remains uncertain. CONTENT: We reviewed studies reporting clinical use of mNGS for pathogen detection from various specimen types, including cerebrospinal fluid, plasma, lower respiratory specimens, and others. Published clinical study data were critically evaluated and summarized to identify promising clinical indications for mNGS-based testing, to assess the clinical impact of mNGS for each indication, and to recognize test limitations. Based on these clinical studies, early testing recommendations are made to guide clinical utilization of mNGS for pathogen detection. Finally, current barriers to routine clinical laboratory implementation of mNGS tests are highlighted. SUMMARY: The promise of direct-from-specimen mNGS to enable challenging infection diagnoses has been demonstrated through early clinical studies of patients with meningitis or encephalitis, invasive fungal infections, community acquired pneumonia, and other clinical indications. However, the proportion of patient cases with positive clinical impact due to mNGS testing is low in published studies and the cost of testing is high, emphasizing the importance of improving our understanding of 'when to test' and for which patients mNGS testing is appropriate.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Filkins LM, Bryson AL, Miller SA, et al. Navigating Clinical Utilization of Direct-from-Specimen Metagenomic Pathogen Detection: Clinical Applications, Limitations, and Testing Recommendations. Clin Chem. 2020. PMID: 33141913. doi:10.1093/clinchem/hvaa183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。